Serena-4

1 trends tracked about this subject — the full history, oldest to newest below.

▲ Peaking Business

AstraZeneca's breast cancer pill Etcamah missed its primary goal in a late-stage trial, adding to oral SERD failures.

6 sources 6 articles v 18 1h ago

\n \n \n

\n \n \n \n